Avantor, Inc., a leading global provider of mission­ critical products and services to customers in the life sciences, advanced technologies, and applied materials industries, today inaugurated its expanded Singapore Hub which includes newly added cGMP manufacturing and a world class quality control laboratory. The hub is a one-stop facility serving the needs of customers across Asia, Middle East, and Africa (AMEA}, strengthening the region's innovation and biopharma ecosystems. 

Strategically located in Singapore, the hub enables quicker turnaround times and expedites customers' access to raw materials that are essential in AMEA's drug discovery and development whilst upholding stringent quality standards.

The inauguration ceremony today was officiated by Avantor executives, Christophe Couturier, and Narayana Rao, Vice President, Biopharma - AMEA, and the Singapore Economic Development Board (EDB), represented by Elaine Teo, Senior Vice President and Head, Investment Facilitation at EDB.

Building onto Avantor's 2022 investment, the integration of the current distribution hub with new manufacturing operations features cGMP suites, quality testing, warehousing of certified products, batch-to-batch traceability and customized palletization capabilities. These state-of­ the-art facilities allow the hub to drive innovation and efficiency to address the immediate challenges in AMEA's biopharma industry.